Fresenius Medical Care AG (FMS)

NYSE: FMS · Real-Time Price · USD

22.74

-0.21 (-0.92%)

At close: Nov 10, 2026, 4:00 PM EST

22.74

0.00 (0.00%)

After-hours: Nov 10, 2026, 4:10 PM EST

Fresenius Medical Care AG Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	11,783	13,366	13,415	12,311	9,586	19,040
Market Cap Growth	-15.31%	-0.36%	8.96%	28.43%	-49.65%	-22.07%
Enterprise Value	23,790	25,324	24,829	26,514	24,928	33,690
Last Close Price	22.95	23.18	21.60	19.48	15.02	29.33

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	13.51	11.64	24.09	22.32	13.32	17.27
PS Ratio	0.53	0.58	0.67	0.57	0.46	0.95
PB Ratio	0.75	0.80	0.82	0.75	0.58	1.20
P/FCF Ratio	5.88	6.45	7.68	5.73	6.21	10.24
P/OCF Ratio	3.66	4.25	5.43	4.24	4.14	6.73

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
EV/Sales Ratio	1.08	1.10	1.24	1.23	1.20	1.68
EV/EBITDA Ratio	7.77	8.23	10.22	9.85	9.29	10.59
EV/EBIT Ratio	10.65	11.54	15.58	15.74	15.17	15.56
EV/FCF Ratio	11.87	12.22	14.22	12.34	16.16	18.12

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	0.79	0.76	0.70	0.82	0.86	0.95
Debt / EBITDA Ratio	3.27	3.31	3.64	3.85	4.06	3.82
Debt / FCF Ratio	6.07	6.12	6.52	6.21	9.15	8.15
Net Debt / Equity Ratio	0.71	0.64	0.61	0.71	0.76	0.84
Net Debt / EBITDA Ratio	3.63	3.46	4.12	4.32	4.68	4.17
Net Debt / FCF Ratio	5.46	5.14	5.73	5.41	8.14	7.14
Asset Turnover	0.63	0.61	0.57	0.56	0.55	0.53
Inventory Turnover	6.37	6.94	6.87	6.49	6.69	6.53
Quick Ratio	0.57	0.85	0.92	0.91	0.85	0.76
Current Ratio	0.99	1.26	1.40	1.42	1.27	1.10
Return on Equity (ROE)	7.84%	7.93%	4.84%	4.84%	6.08%	9.27%
Return on Assets (ROA)	3.94%	3.62%	2.85%	2.73%	2.74%	3.60%
Return on Invested Capital (ROIC)	6.48%	6.04%	4.25%	4.11%	4.27%	6.01%
Return on Capital Employed (ROCE)	8.40%	7.60%	5.50%	5.50%	5.30%	7.00%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Nov '26 Nov 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	7.40%	8.59%	4.15%	4.48%	7.51%	5.79%
FCF Yield	17.01%	15.51%	13.02%	17.46%	16.09%	9.77%
Dividend Yield	2.67%	3.66%	3.26%	3.14%	3.66%	2.36%
Payout Ratio	35.88%	43.19%	64.91%	65.86%	58.74%	40.49%
Buyback Yield / Dilution	6.82%	0.76%	-	-0.06%	-0.06%	0.41%
Total Shareholder Return	9.49%	4.41%	3.26%	3.08%	3.60%	2.77%

SEC Filings: 10-K · 10-Q